The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Amed Salah since year 2005.
The trader's CIK number is 1237250.
At the time of this reporting, Amed Salah is the Sr.VP, R&D of Barr Pharmaceuticals Inc .
(stock ticker symbol BRL).
See this page for all insider trading activities at Barr Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2006-01-10||BRL||Barr Pharmaceuticals Inc||Sale||45,800||66.62||3,051,287|
|2006-01-09||BRL||Barr Pharmaceuticals Inc||Sale||4,804||66.54||319,634|
|2006-01-04||BRL||Barr Pharmaceuticals Inc||Sale||26,537||63.25||1,678,465|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Amed Salah (Sr.VP, R&D of Barr Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.